Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese rats

BMC Complementary and Alternative Medicine

Volumn 16, Issue 1, 2016, Pages

  Mashmoul, Maryam ^a   Azlan, Azrina ^a,b   Mohtarrudin, Norhafizah ^a   Mohd Yusof, Barakatun Nisak ^a,b   Khaza'ai, Huzwah ^a   Khoo, Hock Eng ^a,b   Farzadnia, Mehdi ^c   Boroushaki, Mohammad Taher ^d  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UPM   (Malaysia)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crocin; Fatty liver; High fat diet; Histopathology; NAFLD; Obesity; Saffron extract

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CROCIN; CROCUS SATIVUS EXTRACT; EOSIN; HEMATOXYLIN; LIVER PROTECTIVE AGENT; SAFFRON EXTRACT; UNCLASSIFIED DRUG; PLANT EXTRACT; PROTECTIVE AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DIET INDUCED OBESITY; HISTOPATHOLOGY; LIMIT OF QUANTITATION; LIPID DIET; LIVER PROTECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; RAT; ADIPOSE TISSUE; ANIMAL; CHEMISTRY; CROCUS; DISEASE MODEL; DRUG EFFECTS; EATING; LIVER; METABOLISM; OBESITY; ORGAN SIZE; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ANIMALS; CROCUS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EATING; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ORGAN SIZE; PLANT EXTRACTS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84992188248     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1381-9     Document Type: Article

References (26)

1. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917-23.
2. Adams LA, Lymp JF, Sauver JS, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113-21.
3. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990;99(5):1408-13.
4. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997;27(1):103-7.
5. Marchesini G, Bianchi G, Tomassetti S, Zoli M, Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet. 2001;358(9285):893-4.
6. Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F. Antioxidant supplements for non alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev. 2007;1:CD004996.
7. Christodoulou E, Kadoglou NP, Kostomitsopoulos N, Valsami G. Saffron: a natural product with potential pharmaceutical applications. J Pharm Pharmacol. 2015;67(12):1634-49.
8. Mashmoul M, Azlan A, Yusof BN, Khaza'ai H, Mohtarrudin N, Boroushaki MT. Effects of saffron extract and crocin on anthropometrical, nutritional and lipid profile parameters of rats fed a high fat diet. J Funct Foods. 2014;8:180-7.
9. Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol. 2002;2(7):7-15.
10. Farahmand SK, Samini F, Samini M, Samarghandian S. Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver. Biogerontology. 2013;14(1):63-71.
11. Kianbakht S, Hashem DF. Anti-obesity and anorectic effects of saffron and its constituent crocin in obese Wistar rat. J Med Plants. 2015;1(53):25-33.
12. Assimopoulou AN, Sinakos Z, Papageorgiou VP. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res. 2005;19(11):997-1000.
13. Chen Y, Zhang H, Tian X, Zhao C, Cai L, Liu Y, et al. Antioxidant potential of crocins and ethanol extracts of Gardenia jasminoides ELLIS and Crocus sativus L.: A relationship investigation between antioxidant activity and crocin contents. Food Chem. 2008;109(3):484-92.
14. Xi L, Qian Z, Xu G, Zheng S, Sun S, Wen N, et al. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. J Nutr Biochem. 2007;18(1):64-72.
15. Arasteh A, Aliyev A, Khamnei S, Delazar A, Mesgari M, Mehmannavaz Y. Crocus sativus on serum glucose, insulin and cholesterol levels in healthy male rats. J Med Plants Res. 2010;4(5):397-402.
16. Shirali S, Zahra Bathaie S, Nakhjavani M. Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. Phytother Res. 2013;27(7):1042-7.
17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313-21.
18. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87(1):1-6.
19. Gajda AM. High fat diets for diet-induced obesity models [Internet]. NJ, USA: Research Diets, Inc.; 2009. Available from: http://www.eps-cjgroup.com/cn/lsg/service/researchdiets/pdf/Obesity%20review.pdf. Accessed 6 Apr 2016.
20. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 2004;279(31):32345-53.
21. Nanji AA, French SW, Freeman JB. Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients. Enzyme. 1985;36(4):266-9.
22. Finco DR. Clinical biochemistry of domestic animals. NY: Academic Press, Inc.; 1989.
23. Bandegi AR, Rashidy-Pour A, Vafaei AA, Ghadrdoost B. Protective effects of Crocus sativus L. extract and crocin against chronic-stress induced oxidative damage of brain, liver and kidneys in rats. Adv Pharm Bull. 2014;4 Suppl 2:493.
24. Rahbani M, Mohajeri D, Rezaie A, Nazeri M. Protective effect of ethanolic extract of saffron (dried stigmas of Crocus sativus L.) on hepatic tissue injury in streptozotocin-induced diabetic rats. J Anim Vet Adv. 2012;11(12):1985-94.
25. Wang CJ, Shiow SJ, Lin JK. Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats. Carcinogenesis. 1991;12(3):459-62.
26. Amin A, Hamza AA, Bajbouj K, Ashraf SS, Daoud S. Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology. 2011;54(3):857-67.